Upstream/downstream glycoprotein IIb/IIIa in non-ST-segment elevation myocardial infarction
- PMID: 16458132
- DOI: 10.1016/j.jacc.2005.11.011
Upstream/downstream glycoprotein IIb/IIIa in non-ST-segment elevation myocardial infarction
Comment on
-
Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial.J Am Coll Cardiol. 2006 Feb 7;47(3):522-8. doi: 10.1016/j.jacc.2005.11.012. Epub 2006 Jan 18. J Am Coll Cardiol. 2006. PMID: 16458130 Clinical Trial.
-
The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis.J Am Coll Cardiol. 2006 Feb 7;47(3):529-37. doi: 10.1016/j.jacc.2005.08.070. Epub 2006 Jan 18. J Am Coll Cardiol. 2006. PMID: 16458131
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical